Digital Outreach Intervention for Lung Cancer Screening

Study summary

mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews. This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.

Ask AI to explain this study

Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedmPATH-Lung and Lung health video

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 25, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Wake Forest University Health Sciences

Study sponsor

Study overview

What this study is about

Purpose: Screening
Study type: Interventional
Phase: Not applicable
Sponsor: Wake Forest University Health Sciences
Interventions being studied: Other: mPATH-Lung; Other: Lung health video

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Meet the Medicare criteria for lung cancer screening, as updated in February 2022:
Age 50 - 77 years
Smoked at least 20 pack years
Current smoker or quit smoking within the past 15 years
Be scheduled to see a primary care provider within the health network in the next 3-4 weeks
Have a patient portal account or cellphone number listed in the electronic health record

Reasons someone may not be able to joinExclusion criteria

Patients flagged as needing a language interpreter in the electronic health record (electronic messages and intervention is delivered in English only).
Those for whom lung cancer screening would be inappropriate:
Prior history of lung cancer
Chest CT within the last 12 months
Those with medical conditions predicting shorter life expectancy
Patients whose home address is not within the state of North Carolina. (Due to telehealth guidelines)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

University of North Carolina- Chapel HillChapel Hill, North Carolina
Wake Forest Baptist Medical CenterWinston-Salem, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 25, 2025. Always confirm current availability with the study team.

View original record ↗